SI1224166T1 - Method of producing n-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, the hydrochloride thereof - Google Patents

Method of producing n-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, the hydrochloride thereof

Info

Publication number
SI1224166T1
SI1224166T1 SI200030273T SI200030273T SI1224166T1 SI 1224166 T1 SI1224166 T1 SI 1224166T1 SI 200030273 T SI200030273 T SI 200030273T SI 200030273 T SI200030273 T SI 200030273T SI 1224166 T1 SI1224166 T1 SI 1224166T1
Authority
SI
Slovenia
Prior art keywords
hydrochloride
guanidine
methanesulfonyl
benzoyl
bis
Prior art date
Application number
SI200030273T
Other languages
English (en)
Slovenian (sl)
Inventor
Rolf Gericke
Manfred Baumgarth
Hans Markus Bender
Bernhard Ladstetter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SI1224166T1 publication Critical patent/SI1224166T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200030273T 1999-10-26 2000-10-11 Method of producing n-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, the hydrochloride thereof SI1224166T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19951418A DE19951418A1 (de) 1999-10-26 1999-10-26 Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid
EP00972725A EP1224166B1 (de) 1999-10-26 2000-10-11 Verfahren zur herstellung von n-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin, hydrochlorid
PCT/EP2000/009977 WO2001030750A1 (de) 1999-10-26 2000-10-11 Verfahren zur herstellung von n-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin, hydrochlorid

Publications (1)

Publication Number Publication Date
SI1224166T1 true SI1224166T1 (en) 2004-04-30

Family

ID=7926842

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030273T SI1224166T1 (en) 1999-10-26 2000-10-11 Method of producing n-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, the hydrochloride thereof

Country Status (26)

Country Link
US (1) US6673968B1 (xx)
EP (1) EP1224166B1 (xx)
JP (1) JP4969750B2 (xx)
KR (1) KR100699571B1 (xx)
CN (1) CN1202078C (xx)
AT (1) ATE250026T1 (xx)
AU (1) AU782471B2 (xx)
BR (1) BR0015022A (xx)
CA (1) CA2388915C (xx)
CZ (1) CZ299201B6 (xx)
DE (2) DE19951418A1 (xx)
DK (1) DK1224166T3 (xx)
ES (1) ES2204712T3 (xx)
HK (1) HK1051358A1 (xx)
HU (1) HU228634B1 (xx)
MX (1) MXPA02004144A (xx)
MY (1) MY122651A (xx)
NO (1) NO328250B1 (xx)
PL (1) PL199010B1 (xx)
PT (1) PT1224166E (xx)
RU (1) RU2276134C2 (xx)
SI (1) SI1224166T1 (xx)
SK (1) SK286603B6 (xx)
UA (1) UA73329C2 (xx)
WO (1) WO2001030750A1 (xx)
ZA (1) ZA200204119B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10023405A1 (de) * 2000-05-12 2001-11-15 Merck Patent Gmbh Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen
DE502004007841D1 (de) * 2003-05-06 2008-09-25 Merck Patent Gmbh Verfahren zur kristallisation von guanidinium-salzen
WO2009135583A1 (en) * 2008-05-09 2009-11-12 Merck Patent Gmbh Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction
JOP20200296A1 (ar) * 2013-06-10 2017-06-16 Amgen Inc عمليات صنع وأشكال بلورية من mdm2 مثبط
WO2015198945A1 (ja) * 2014-06-23 2015-12-30 日産化学工業株式会社 スルホニル結合を有するシラン化合物の製造方法
CN117304079A (zh) * 2016-02-08 2023-12-29 默克专利股份有限公司 N-(4,5-双甲磺酰基-2-甲基苯甲酰基)胍盐酸盐和n-(4,5-双甲磺酰基-2-甲基苯甲酰基)胍盐的结晶变体
EP3960165A1 (en) * 2020-08-25 2022-03-02 Fondation EspeRare Nhe-1 inhibitors for the treatment of coronavirus infections

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216865A (ja) * 1983-05-26 1984-12-06 Mitsui Toatsu Chem Inc システイン塩酸塩水和物の乾燥方法
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
ATE147375T1 (de) * 1992-09-22 1997-01-15 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, sowie ihre verwendung als antiarrhythmika
EP0604852A1 (de) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
JP3755908B2 (ja) * 1994-08-17 2006-03-15 塩野義製薬株式会社 セファロスポリン化合物の晶析法
DK0723956T3 (da) * 1995-01-30 2000-04-17 Hoechst Ag Basisk substituerede benzoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnos
DE19502895A1 (de) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
DE19529612A1 (de) * 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate

Also Published As

Publication number Publication date
CA2388915C (en) 2009-12-15
CN1202078C (zh) 2005-05-18
UA73329C2 (uk) 2005-07-15
BR0015022A (pt) 2002-06-18
KR20020044572A (ko) 2002-06-15
HK1051358A1 (en) 2003-08-01
CZ20021354A3 (cs) 2002-09-11
DE50003759D1 (de) 2003-10-23
MXPA02004144A (es) 2006-01-12
ATE250026T1 (de) 2003-10-15
EP1224166A1 (de) 2002-07-24
WO2001030750A1 (de) 2001-05-03
JP2003512451A (ja) 2003-04-02
AU782471B2 (en) 2005-08-04
DE19951418A1 (de) 2001-05-03
RU2276134C2 (ru) 2006-05-10
JP4969750B2 (ja) 2012-07-04
SK5462002A3 (en) 2002-10-08
MY122651A (en) 2006-04-29
CZ299201B6 (cs) 2008-05-14
DK1224166T3 (da) 2004-01-05
NO20021950L (no) 2002-04-25
ES2204712T3 (es) 2004-05-01
NO328250B1 (no) 2010-01-18
CA2388915A1 (en) 2001-05-03
PL199010B1 (pl) 2008-08-29
AU1136101A (en) 2001-05-08
HUP0203132A2 (hu) 2003-01-28
CN1382120A (zh) 2002-11-27
SK286603B6 (sk) 2009-02-05
US6673968B1 (en) 2004-01-06
KR100699571B1 (ko) 2007-03-23
EP1224166B1 (de) 2003-09-17
NO20021950D0 (no) 2002-04-25
HUP0203132A3 (en) 2004-12-28
PT1224166E (pt) 2004-02-27
HU228634B1 (en) 2013-04-29
ZA200204119B (en) 2003-10-29
PL355149A1 (en) 2004-04-05

Similar Documents

Publication Publication Date Title
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
HK1023987A1 (en) Sulphinic acid derivatives, method for producing, and their use
DE60236102D1 (en) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
AU2002224893A1 (en) Method for producing a part and device for carrying out this method
IL154122A0 (en) Crystalline and pure modafinil, and process of preparing the same
HUP0100760A3 (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives, process for producing them and pharmaceutical compositions containing them
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
RS11304A (xx) Novi kristalni polimorfni oblici lerkanidipin hidrohlorida i postupak za njihovo dobijanje
ZA200204119B (en) Method of producing N-(4,5-bis-methanesulfonyl-2-methylbenzoyl)-guanidine, the hydrochloride thereof.
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
HK1080077A1 (zh) 非肽的brs-3激動劑
WO2001002350A3 (de) Neue amino- und amidosulfonamide als antivirale mittel
MXPA04004937A (es) Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
DK0703232T3 (da) 2,3-Dihydro-1H-isoindolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som hæmmere af serotoningenoptagelsen
HUP0303478A3 (en) Method of producing n-substituted 2,6-dialkyl morpholines
ATE242763T1 (de) Methoximinophenylessigsäureamide
DK1246790T3 (da) Substituerede 1- og 2-naphthol-Mannichbaser
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
DE60131660D1 (de) Verfahren zur asymetrischen synthese von substituierten 1,4-dihydropyridin-derivaten
AR026231A1 (es) Proceso para preparar clorhidrato de n-(4,5-bis-metansulfonil-2-metilbenzoil)-guanidina
HU0101721D0 (en) Process for producing of n,n'-carbonil-bis(lactams)
TH20016A (th) กลูโคไพแรโนไซด์ เบนโซไธโอฟีน
RO116896B1 (ro) Derivaţi pseudocarbaciclinici şi procedeu pentru prepararea acestora
DK1268441T3 (da) Mellemprodukt og fremgangsmåde til dets syntese
ITMI920720A1 (it) Forma cristallina dell'endo-3-etil-2, 3-diidro-n-(8-metil-8-azabiciclo (3. 2. 1) ott-3-il)- 2-oxo-1h-benzimidazolo-1-carbossamide cloridrato